CSPC Pharmaceutical Group Ltd 01093
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover 01093, but with our powerful screener, you can find
stocks in the same sector,industry, or style and filter on our unbiased ratings and valuation metrics.
News
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Value
- Total Number of Employees
- 20,300
- Website
- https://www.cspc.com.hk
Comparables
Valuation
|
Metric
|
01093
|
02096
|
03692
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 21.49 | 33.79 |
Price/Book Value | — | 2.08 | 4.04 |
Price/Sales | — | 2.37 | 9.21 |
Price/Cash Flow | — | 14.07 | 25.65 |
Price/Earnings
01093
02096
03692
Financial Strength
|
Metric
|
01093
|
02096
|
03692
|
|---|---|---|---|
Quick Ratio | 2.20 | 1.84 | 7.81 |
Current Ratio | 2.54 | 2.10 | 7.98 |
Interest Coverage | 196.14 | 20.82 | 68.15 |
Quick Ratio
01093
02096
03692
Profitability
|
Metric
|
01093
|
02096
|
03692
|
|---|---|---|---|
Return on Assets (Normalized) | 13.78% | 6.97% | 14.94% |
Return on Equity (Normalized) | 19.03% | 10.22% | 18.77% |
Return on Invested Capital (Normalized) | 17.32% | 8.48% | 14.08% |
Return on Assets
01093
02096
03692
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Ybjcjthll | Tpdq | $818.8 Bil | |||
| Johnson & Johnson
JNJ
| Mdlznxxg | Kvds | $388.5 Bil | |||
| AbbVie Inc
ABBV
| Gybywsr | Nhf | $339.0 Bil | |||
| Merck & Co Inc
MRK
| Hgxbncbbm | Cqv | $286.7 Bil | |||
| Roche Holding AG ADR
RHHBY
| Sgrmnmvcg | Dlxkj | $255.9 Bil | |||
| AstraZeneca PLC ADR
AZN
| Flfjtqklcz | Qkbf | $241.9 Bil | |||
| Novartis AG ADR
NVS
| Vwfvbdvv | Ptczp | $233.0 Bil | |||
| Amgen Inc
AMGN
| Fwgbddjdt | Qvqjk | $171.5 Bil | |||
| Pfizer Inc
PFE
| Khvsvlvr | Rcjgy | $164.2 Bil | |||
| Sanofi SA ADR
SNY
| Jhrpprxsn | Vchf | $142.8 Bil |
United States